LeMaitre Vascular, Inc. (LMAT) - NASDAQ
  • Wed, Jul. 27, 4:25 PM
    • LeMaitre Vascular (NASDAQ:LMAT): Q2 EPS of $0.14 beats by $0.03.
    • Revenue of $22.4M (+12.6% Y/Y) beats by $0.88M.
    • Press Release
    | Wed, Jul. 27, 4:25 PM | 1 Comment
  • Mon, May 2, 4:28 PM
    • LeMaitre Vascular (NASDAQ:LMAT): Q1 EPS of $0.11 beats by $0.01.
    • Revenue of $20.3M (+7.1% Y/Y) beats by $0.1M.
    • Press Release
    | Mon, May 2, 4:28 PM | 1 Comment
  • Wed, Feb. 24, 4:11 PM
    • LeMaitre Vascular (NASDAQ:LMAT): Q4 EPS of $0.13 beats by $0.04.
    • Revenue of $21.36M (+14.3% Y/Y) beats by $1.26M.
    • Press Release
    | Wed, Feb. 24, 4:11 PM
  • Oct. 28, 2015, 10:59 AM
    • LeMaitre Vascular (LMAT +9.3%) Q3 results: Revenues: $19M (+8.6%); COGS: $5.5M (+0.2%); R&D Expense: $1.4M (+27.3%); SG&A: $8.9M (+1.0%); Operating Income: $3.3M (+73.7%); Net Income: $2.1M (+133.3%); EPS: $0.11 (+120.0%); Quick Assets: $23.6M (+26.2%).
    • 2015 Guidance: Revenue: $78M; Operating Income: $11M.
    | Oct. 28, 2015, 10:59 AM
  • Oct. 27, 2015, 4:15 PM
    • LeMaitre Vascular (NASDAQ:LMAT): Q3 EPS of $0.11 beats by $0.03.
    • Revenue of $19M (+8.6% Y/Y) beats by $0.18M.
    | Oct. 27, 2015, 4:15 PM
  • Jul. 28, 2015, 4:26 PM
    • LeMaitre Vascular (NASDAQ:LMAT): Q2 EPS of $0.10 beats by $0.03.
    • Revenue of $19.9M (+9.6% Y/Y) beats by $1.07M.
    | Jul. 28, 2015, 4:26 PM
  • Apr. 28, 2015, 4:15 PM
    • LeMaitre Vascular (NASDAQ:LMAT): Q1 EPS of $0.08 beats by $0.03.
    • Revenue of $18.9M (+12.8% Y/Y) beats by $1.14M.
    | Apr. 28, 2015, 4:15 PM
  • Feb. 25, 2015, 4:30 PM
    • LeMaitre Vascular (NASDAQ:LMAT): Q4 EPS of $0.11 beats by $0.04.
    • Revenue of $18.68M (+4.2% Y/Y) misses by $0.22M.
    | Feb. 25, 2015, 4:30 PM
  • Oct. 29, 2014, 10:21 AM
    • LeMaitre Vascular (LMAT +0.8%) Q3 results: Revenues: $17.5M (+14.4%); Gross Profit: $12M (+12.1%); Operating Expenses: $10M (+2.0%); Operating Income: $1.9M (+137.5%); Net Income: $1M (+42.9%); EPS: $0.05 (unch); Quick Assets: $18.4M (+25.2%).
    • 2014 Guidance: Sales: $71.3M ; operating income: $5.7M .
    • Q4 Guidance: Sales: $18.9 M ; operating income: $2.1M .
    | Oct. 29, 2014, 10:21 AM
  • Oct. 28, 2014, 4:56 PM
    • LeMaitre Vascular (NASDAQ:LMAT): Q3 EPS of $0.05 in-line.
    • Revenue of $17.5M (+14.4% Y/Y) beats by $0.41M.
    | Oct. 28, 2014, 4:56 PM
  • Oct. 21, 2014, 12:38 PM
    • LaMaitre Vascular (LMAT +0.6%) will report Q3 results on October 28 after the close. The conference call will begin at 5:00 pm ET.
    • Consensus view is EPS of $0.05 on revenues of $17M.
    | Oct. 21, 2014, 12:38 PM
  • Jul. 29, 2014, 9:03 PM
    • LeMaitre Vascular (LMAT +1.5%) Q2 results: Net Sales: $18.2M (+13.8%); Gross Profit: $12.4M (+10.7%); Operating Expenses: $10.4M (+6.1%); Operating Income: $2.0M (+42.9%); Net Income: $1.3M (+44.4%); EPS: $0.08 (+33.3%); Quick Assets: $23.5M (+59.9%).
    • 2014 Guidance: Sales: $70.1M, XenoSure sales: $10.0M; operating income: $5.6M.
    • Q3 Guidance: Sales: $17.1M; operating income: $1.4M.
    | Jul. 29, 2014, 9:03 PM
  • Jul. 29, 2014, 5:48 PM
    • LeMaitre Vascular (NASDAQ:LMAT): Q2 EPS of $0.08 beats by $0.03.
    • Revenue of $18.16M (+13.9% Y/Y) beats by $0.62M.
    | Jul. 29, 2014, 5:48 PM
  • Oct. 29, 2013, 6:57 PM
    • LeMaitre (LMAT): Q3 EPS of $0.05 beats by $0.01.
    • Revenue of $15.3M beats by $0.07M. (PR)
    | Oct. 29, 2013, 6:57 PM
  • Jul. 31, 2013, 6:14 AM
    • LeMaitre (LMAT): Q2 EPS of $0.06 beats by $0.01.
    • Revenue of $16M beats by $0.54M. (PR)
    | Jul. 31, 2013, 6:14 AM
Company Description
LeMaitre Vascular, Inc. is a medical device company, which provides innovative devices for the treatment of peripheral vascular disease. The company develops, manufactures and markets disposable and implantable vascular devices to address the needs of vascular surgeons. Its products line include... More
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States